Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Stifel Downgrades Bio-Techne to Hold, Announces $65 Price Target

Author: Benzinga Newsdesk | February 02, 2024 07:41am
Stifel analyst Daniel Arias downgrades Bio-Techne (NASDAQ:TECH) from Buy to Hold and announces $65 price target.

Posted In: TECH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist